Disseminated intravascular coagulation risk factors: Difference between revisions
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of DIC include trauma, sepsis, obstetric complications, cancers, and immunologic reactions | Common risk factors in the development of [[DIC]] include [[trauma]], [[sepsis]], [[obstetric]] complications, [[cancers]], and [[Immunological|immunologic]] reactions | ||
==Risk Factors== | ==Risk Factors== | ||
Common risk factors in the development of DIC include:<ref name="pmid10451465">{{cite journal |vauthors=Levi M, Ten Cate H |title=Disseminated intravascular coagulation |journal=N. Engl. J. Med. |volume=341 |issue=8 |pages=586–92 |date=August 1999 |pmid=10451465 |doi=10.1056/NEJM199908193410807 |url=}}</ref><ref name="pmid11583315">{{cite journal |vauthors=Sallah S, Wan JY, Nguyen NP, Hanrahan LR, Sigounas G |title=Disseminated intravascular coagulation in solid tumors: clinical and pathologic study |journal=Thromb. Haemost. |volume=86 |issue=3 |pages=828–33 |date=September 2001 |pmid=11583315 |doi= |url=}}</ref> | Common risk factors in the development of DIC include:<ref name="pmid10451465">{{cite journal |vauthors=Levi M, Ten Cate H |title=Disseminated intravascular coagulation |journal=N. Engl. J. Med. |volume=341 |issue=8 |pages=586–92 |date=August 1999 |pmid=10451465 |doi=10.1056/NEJM199908193410807 |url=}}</ref><ref name="pmid11583315">{{cite journal |vauthors=Sallah S, Wan JY, Nguyen NP, Hanrahan LR, Sigounas G |title=Disseminated intravascular coagulation in solid tumors: clinical and pathologic study |journal=Thromb. Haemost. |volume=86 |issue=3 |pages=828–33 |date=September 2001 |pmid=11583315 |doi= |url=}}</ref>.<ref name="pmid23139140">{{cite journal |vauthors=Singh B, Hanson AC, Alhurani R, Wang S, Herasevich V, Cartin-Ceba R, Kor DJ, Gangat N, Li G |title=Trends in the incidence and outcomes of disseminated intravascular coagulation in critically ill patients (2004-2010): a population-based study |journal=Chest |volume=143 |issue=5 |pages=1235–1242 |date=May 2013 |pmid=23139140 |doi=10.1378/chest.12-2112 |url=}}</ref><ref name="pmid9393338">{{cite journal |vauthors=Smith OP, White B, Vaughan D, Rafferty M, Claffey L, Lyons B, Casey W |title=Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans |journal=Lancet |volume=350 |issue=9091 |pages=1590–3 |date=November 1997 |pmid=9393338 |doi= |url=}}</ref><ref name="pmid9923809">{{cite journal |vauthors=Gando S, Nanzaki S, Kemmotsu O |title=Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma: application of clinical decision analysis |journal=Ann. Surg. |volume=229 |issue=1 |pages=121–7 |date=January 1999 |pmid=9923809 |pmc=1191617 |doi= |url=}}</ref> | ||
* [[Trauma]] | |||
* Trauma | * [[Sepsis]] | ||
* Sepsis | * [[Obstetric]] complications | ||
* Obstetric complications | * [[Cancers]] | ||
* Cancers | * [[Immunological|Immunologic]] reactions | ||
* Immunologic reactions | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Latest revision as of 14:33, 30 August 2018
Disseminated intravascular coagulation Microchapters |
Differentiating Disseminated intravascular coagulation from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Disseminated intravascular coagulation risk factors On the Web |
American Roentgen Ray Society Images of Disseminated intravascular coagulation risk factors |
Disseminated intravascular coagulation risk factors in the news |
Blogs on Disseminated intravascular coagulation risk factors |
Directions to Hospitals Treating Disseminated intravascular coagulation |
Risk calculators and risk factors for Disseminated intravascular coagulation risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2]
Overview
Common risk factors in the development of DIC include trauma, sepsis, obstetric complications, cancers, and immunologic reactions
Risk Factors
Common risk factors in the development of DIC include:[1][2].[3][4][5]
- Trauma
- Sepsis
- Obstetric complications
- Cancers
- Immunologic reactions
References
- ↑ Levi M, Ten Cate H (August 1999). "Disseminated intravascular coagulation". N. Engl. J. Med. 341 (8): 586–92. doi:10.1056/NEJM199908193410807. PMID 10451465.
- ↑ Sallah S, Wan JY, Nguyen NP, Hanrahan LR, Sigounas G (September 2001). "Disseminated intravascular coagulation in solid tumors: clinical and pathologic study". Thromb. Haemost. 86 (3): 828–33. PMID 11583315.
- ↑ Singh B, Hanson AC, Alhurani R, Wang S, Herasevich V, Cartin-Ceba R, Kor DJ, Gangat N, Li G (May 2013). "Trends in the incidence and outcomes of disseminated intravascular coagulation in critically ill patients (2004-2010): a population-based study". Chest. 143 (5): 1235–1242. doi:10.1378/chest.12-2112. PMID 23139140.
- ↑ Smith OP, White B, Vaughan D, Rafferty M, Claffey L, Lyons B, Casey W (November 1997). "Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans". Lancet. 350 (9091): 1590–3. PMID 9393338.
- ↑ Gando S, Nanzaki S, Kemmotsu O (January 1999). "Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma: application of clinical decision analysis". Ann. Surg. 229 (1): 121–7. PMC 1191617. PMID 9923809.